Patent · US Active

Method for assaying sepsis in humans

US9857381B2 · kind B2 · utility

0Cited by
0References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 29, 2013
Grant dateJan 2, 2018
Priority date
Expiry dateJan 31, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/26
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention relates to a reliable method of prediction of sepsis in humans after a trauma, wherein the level of pancreatic stone protein/regenerating protein (PSP/reg) is determined in serum, and a high level is indicative of the development of sepsis at early stages of the disease. Furthermore a method of determination of PSP/reg levels in serum is described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.